Astellas Pharma Inc. (TYO:4503) recently announced that it has agreed to acquire Audentes Therapeutics Inc., a U.S.-based venture specializing in…...
Please subscribe to read the full story.
rare diseases
Interview: Takeda Pharmaceutical CEO Talks Shire Deal, Shifting Business Structure – Part 2
Takeda Pharmaceutical Co. Ltd. (TYO:4502) has recently made waves in the pharmaceutical industry with its move to acquire Irish-based drug…...
Please subscribe to read the full story.
